News Daily News Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES September 14, 2011
News Daily News Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES September 12, 2011
News Daily News ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions Jason Kahn September 12, 2011
News Daily News Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions Jason Kahn September 08, 2011
News Conference News Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS September 02, 2011
News Conference News Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy September 02, 2011
News Conference News RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority August 31, 2011
News Daily News TRIAS HR Published: Genous Stent Doubles Target Lesion Failure Leah Lawrence August 23, 2011
News Daily News No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients L.A. McKeown August 19, 2011
News Daily News Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease Jason Kahn August 08, 2011
News Daily News SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year Caitlin E. Cox August 05, 2011
News Daily News ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics Caitlin E. Cox August 03, 2011
News Daily News Meta-analysis Finds Equivalence Between First-, Second-Generation DES L.A. McKeown August 02, 2011
News Daily News ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute Jason Kahn July 21, 2011
News Industry News NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications July 18, 2011